Flagship Ventures Fund IV General Partner’s Carisma Therapeutics CARM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q2	$2.46M	Buy	+73,321	New	+$2.46M	0.42%	5
2015 Q4	$4.41M	Buy	+73,321	New	+$4.41M	0.87%	3